Drug Information

Drug General Information
Drug ID
D03BSK
Former ID
DIB010870
Drug Name
URC102
Indication Gout [ICD9: 274.00274.1274.8274.9; ICD10:M10] Phase 2 [524997]
Target and Pathway
Target(s) Solute carrier family 22 member 12 Target Info Inhibitor [550551]
WikiPathways Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 524997ClinicalTrials.gov (NCT02290210) Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients. U.S. National Institutes of Health.
Ref 550551Clinical pipeline report, company report or official report of Chugai Pharmaceutical (2013).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.